Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shyam Prakash Dumre is active.

Publication


Featured researches published by Shyam Prakash Dumre.


American Journal of Tropical Medicine and Hygiene | 2013

Dengue Virus and Japanese Encephalitis Virus Epidemiological Shifts in Nepal: A Case of Opposing Trends

Shyam Prakash Dumre; Geeta Shakya; Kesara Na-Bangchang; Veerachai Eursitthichai; Hans Rudi Grams; Senendra R. Upreti; Prakash Ghimire; Khagendra Kc; Ananda Nisalak; Robert V. Gibbons; Stefan Fernandez

We report on the changing epidemiology of two important flaviviruses in Nepal: Japanese encephalitis (JE) and dengue viruses. Morbidity and mortality in Nepal is in the thousands since JE was introduced in 1978. Nepal launched an extensive laboratory-based JE surveillance in 2004. Nepal experienced a remarkable reduction in disease burden after mass immunizations from 2005 to 2010, when 2,040 JE infections and 205 JE-related deaths were confirmed. With its emergence in 2006, dengue has become a significant challenge in the country, highlighted by a sudden outbreak in 2010 that resulted in 359 confirmed dengue infections. Currently, both viruses cocirculate in Nepal. Here, we document the remarkable expansion of dengue in Nepal, which urgently requires national surveillance to refine the burden and make recommendations regarding control and prevention programs. We believe that the use of existing JE surveillance network for integrated dengue surveillance may represent the most appropriate alternative.


Malaria Journal | 2013

Community-directed educational intervention for malaria elimination in Bhutan: quasi-experimental study in malaria endemic areas of Sarpang district

Tashi Tobgay; Deki Pem; Ugyen Dophu; Shyam Prakash Dumre; Kesara Na-Bangchang; Cristina E. Torres

BackgroundAs per the World Malaria Report 2011, there was a 17% reduction in morbidity and 26% reduction in mortality in 2010, compared to 2000. In Bhutan, there were only 194 malaria cases in 2011 as compared to 5,935 cases in 2000. As the country moves towards an elimination phase, educating the community and empowering them on malaria prevention and control is imperative. Hence, this study was conducted to elucidate the effectiveness of the community-directed educational intervention on malaria prevention and control in malaria-endemic areas of Sarpang district, Bhutan.MethodsThis quasi-experimental study design was conducted using both qualitative and quantitative data collection methods. In-depth interviews and focus group discussions were carried out in addition to household survey using a structured questionnaire conducted before and after the intervention. Intervention was conducted using community action groups, who were provided with training and which then developed action plans for implementation of interventions within their communities.ResultsThe study resulted in a significant improvement in knowledge and attitude in intervention as compared to control during the post-intervention survey (p < 0.001). The practice score was higher in the control group both during pre- and post-intervention, however, the mean ( ±sd) score of practice in intervention group increased from 6.84 ± 1.26 in pre-intervention to 8.35 ± 1.14 in post-intervention (p < 0.001), where as it decreased from 9.19 ± 1.78 to 9.10 ± 1.98 in the control group (p = 0. 68). When comparing pre- and post- in the intervention group, there was significant improvement during post-intervention in knowledge, attitude and practice (p < 0.001).ConclusionsThe findings from this study corroborate that community-directed interventions can be utilized as an effective means for improving knowledge, attitude and practice in the malaria-endemic areas of Bhutan. Further studies are needed to see the long-term effect and sustainability of such interventions.


BioMed Research International | 2016

Virological and Immunological Status of the People Living with HIV/AIDS Undergoing ART Treatment in Nepal

Chet Raj Ojha; Geeta Shakya; Shyam Prakash Dumre

Antiretroviral therapy (ART) has increased the life span of the people living with HIV (PLHIV), but their virological and immunological outcomes are not well documented in Nepal. The study was conducted at a tertiary care center including 826 HIV-1 seropositive individuals undergoing ART for at least six months. Plasma viral load (HIV-1 RNA) was detected by Real Time PCR and CD4+ T-lymphocyte (CD4+) counts were estimated by flow cytometry. The mean CD4+ count of patients was 501 (95% CI = 325–579) cells/cumm, but about 35% of patients had CD4+ T cell counts below 350 cells/cumm. With increasing age, average CD4+ count was found to be decreasing (p = 0.005). Of the total cases, 82 (9.92%) were found to have virological failure (viral load: >1000 copies/ml). Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV), the frequently used ART regimen in Nepal, showed virological failure in 11.34% and immunological failure in 37.17% of patients. Virological failure rate was higher among children < 15 years (14.5%) (p = 0.03); however, no association was observed between ART outcomes and gender or route of transmission. The study suggests there are still some chances of virological and immunological failures despite the success of highly active ART (HAART).


American Journal of Tropical Medicine and Hygiene | 2017

Dengue Virus Serotypes 1 and 2 Responsible for Major Dengue Outbreaks in Nepal: Clinical, Laboratory, and Epidemiological Features.

Kenji Hirayama; Mahamoud Sama Cherif; Stefan Fernandez; In-Kyu Yoon; Sanjaya K. Shrestha; Chonticha Klungthong; Geeta Shakya; Kesara Na-Bangchang; Prakash Ghimire; Renu Bhandari; Shyam Prakash Dumre

Abstract. Dengue virus (DENV) is expanding toward previously nonendemic areas. DENV has recently been introduced in Nepal with limited information. We report the clinical features and serotype distribution of DENV in Nepal during the 2010 outbreaks. A total of 1,215 clinical dengue cases at two major hospitals of central and western Nepal were investigated. Demographic, clinical, and laboratory parameters were recorded. Serum specimens were tested for DENV by IgM/IgG enzyme-linked immunosorbent assays (ELISAs) and reverse transcription polymerase chain reaction (RT-PCR). We confirmed DENV infection in 403 (33%) patients from 12 districts with an estimated case fatality rate of 1.5%. DENV infection was more common in adults (87%) and urban settings (74%). We detected all four serotypes but DENV-1 and -2 were mainly responsible for major outbreaks (92%). Overall, 60% of all DENV infections were secondary and 17% were severe dengue; both being more frequent among the DENV-2 infections. Rash, bleeding, abdominal pain, hepatomegaly, elevated liver enzymes, and thrombocytopenia were significantly more common in severe dengue compared with nonsevere infections. We also confirmed the expansion of dengue to hill urban areas (DENV-1 and -2), including the capital Kathmandu (altitude, 1,300 m) though > 90% cases were from southern plains. Differential clinical and laboratory features probably help in clinical decisions. Multiple serotypes circulation and elevated secondary infections pose potential risk of severe outbreaks and deaths in the future. Therefore, a country with recent dengue introduction, like Nepal, urgently requires a systematic surveillance and appropriate control measures in place to respond to any disastrous outbreaks.


Japanese Journal of Infectious Diseases | 2010

Cholera incidence among patients with diarrhea visiting National Public Health Laboratory, Nepal.

Rabindra Karki; Dwij Raj Bhatta; Sarala Malla; Shyam Prakash Dumre


World Journal of Microbiology & Biotechnology | 2012

Phenotypic and genetic characterization of Vibrio cholerae O1 clinical isolates collected through national antimicrobial resistance surveillance network in Nepal.

Geeta Shakya; Dong Wook Kim; John D. Clemens; Sarala Malla; Bishnu Upadhyaya; Shyam Prakash Dumre; Sirjana Devi Shrestha; Shailaja Adhikari; Supriya Sharma; Nisha Rijal; Sanjaya K. Shrestha; Carl J. Mason; Palpasa Kansakar


Kathmandu University Medical Journal | 2012

Current fluoroquinolone susceptibility criteria for Salmonella needs re-evaluation.

D Acharya; Sarala Malla; Bhatta; N Adhikari; Shyam Prakash Dumre


International Journal of Infectious Diseases | 2012

Molecular characterization of dengue virus from Nepal

Shyam Prakash Dumre; Kesara Na-Bangchang; Veerachai Eursitthichai; V. Viyanant; R. Grams; Geeta Shakya; C. Klungthong; A. Nisalak; S. Fernandez


Archive | 2013

Short Report: Dengue Virus and Japanese Encephalitis Virus Epidemiological Shifts in Nepal: A Case of Opposing Trends

Shyam Prakash Dumre; Geeta Shakya; Kesara Na-Bangchang; Veerachai Eursitthichai; Hans Rudi Grams; Senendra R. Upreti; Prakash Ghimire; Khagendra Kc; Ananda Nisalak; Robert V. Gibbons; Stefan Fernandez


Journal of Nepal Medical Association | 2012

Values of Lymphocyte Subsets in Nepalese Healthy Adult Population

Geeta Shakya; Shyam Prakash Dumre; Sarala Malla; M Sharma; K P Kc; D B Chhetri; R Amatya; P Paudyal

Collaboration


Dive into the Shyam Prakash Dumre's collaboration.

Top Co-Authors

Avatar

Geeta Shakya

Public health laboratory

View shared research outputs
Top Co-Authors

Avatar

Sarala Malla

Public health laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Stefan Fernandez

United States Army Medical Research Institute of Infectious Diseases

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

R. Grams

Thammasat University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge